Literature DB >> 23432595

Sulfonamide-metal complexes endowed with potent anti-Trypanosoma cruzi activity.

Zahid H Chohan1, Marcelo Zaldini Hernandes, Fabricio R Sensato, Diogo Rodrigo Magalhaes Moreira, Valéria Rego Alves Pereira, Juliana Kelle de Andrade Lemoine Neves, Andresa Pereira de Oliveira, Beatriz Coutinho de Oliveira, Ana Cristina Lima Leite.   

Abstract

In this article, we describe that mononuclear complexes composed of (5-chloro-2-hydroxybenzylidene)aminobenzenesulfonamides (L1-3) of general formula (L2(M)2H2O, where M is Co, Cu, Zn, Ni or Mn) reduced epimastigote proliferation and were found cidal for trypomastigotes of Trypanosoma cruzi Y strain. Complexes C5 and C11 have IC50 of 2.7 ± 0.27 and 4.8 ± 0.47 µM, respectively, for trypomastigotes, when the positive control Nifurtimox, which is also an approved drug for Chagas disease, showed IC50 of 2.7 ± 0.25 µM. We tested whether these complexes inhibit the enzyme T. cruzi trypanothione reductase or acting as DNA binders. While none of these complexes inhibited trypanothione reductase, we observed some degree of DNA binding, albeit less pronounced than observed for cisplatin in this assay. Unfortunately, most of these complexes were also toxic for mouse splenocytes. Along with the present studies, we discuss a number of interesting structure-activity relationships and chemical features for these metal complexes, including computational calculations.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23432595     DOI: 10.3109/14756366.2013.766608

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  2 in total

Review 1.  Chelation in Antibacterial Drugs: From Nitroxoline to Cefiderocol and Beyond.

Authors:  Davorka Repac Antić; Marijo Parčina; Ivana Gobin; Mirna Petković Didović
Journal:  Antibiotics (Basel)       Date:  2022-08-15

2.  Message in a molecule.

Authors:  Tanmay Sarkar; Karuthapandi Selvakumar; Leila Motiei; David Margulies
Journal:  Nat Commun       Date:  2016-05-03       Impact factor: 14.919

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.